Stock Chart

XLO

$9.01 +1.12%
Score: 59.4 HOLD
Pro
Screener
Vol: 0.76x (vs SPY: 0.8x | vs QQQ: 0.7x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 02, 2026
Descending Triangle Bearish scenario quality 64/100
Measured-move target $8.31 (-7.7%) · apex ~57 bars ahead
Break direction historically ~even (52% up, n=87) — scenario shown, not a forecast
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About XLO - Xilio Therapeutics, Inc. Common Stock

Xilio Therapeutics Inc is a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology (I-O) therapies with the goal of significantly improving outcomes for people living with cancer without the systemic side effects of current I-O treatments. The company is using its proprietary platform to advance a pipeline of novel, tumor-activated clinical and preclinical I-O molecules that are designed to optimize the therapeutic index by localizing anti-tumor activity within the tumor microenvironment, including tumor-activated cytokines and antibodies (including bispecifics) and immune …

Key Statistics

Market Cap $59M

This XLO stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track XLO's price movements with trendlines, gamma walls, and key support/resistance levels.